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Phosphoinositides are involved in endocytosis in both
mammalian cells and the amoeba Dictyostelium discoi-
deum. Dd5P4 is the Dictyostelium homolog of human
OCRL (oculocerebrorenal syndrome of Lowe); both have
a RhoGAP domain and a 5-phosphatase domain that acts
on phosphatidylinositol 4,5-bisphosphate/phosphatidyli-
nositol 3,4,5-trisphosphate (PI(3,4,5)P3). Inactivation of
Dd5P4 inhibits growth on liquid medium and on bacteria.
Dd5p4-null cells are impaired in phagocytosis of yeast
cells. In wild-type cells, PI(3,4,5)P3 is formed and con-
verted to PI(3,4)P2 just before closure of the phagocytic
cup. In dd5p4-null cells, a phagocytic cup is formed upon
contact with the yeast cell, and PI(3,4,5)P3 is still pro-
duced, but the phagocytic cup does not close. We sug-
gest that Dd5P4 regulates the conversion of PI(3,4,5)P3 to
PI(3,4)P2 and that this conversion is essential for closure
of the phagocytic cup. Phylogenetic analysis of OCRL-like
5-phosphatases with RhoGAP domains reveal that D.
discoideum Dd5P4 is a surprisingly close homolog of
human OCRL, the protein responsible for Lowe syn-
drome. We expressed human OCRL in dd5p4-null cells.
Growth on bacteria and axenic medium is largely
restored, whereas the rate of phagocytosis of yeast cells
is partly restored, indicating that human OCRL can
functionally replace Dictyostelium Dd5P4.
Key words: OCRL, phagocytosis, 5-phosphatase, phos-
phoinositide, pinocytosis
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Many processes, including vesicle trafficking, are regu-
lated by phosphoinositides (1,2). Binding of phosphoinosi-
tides to protein domains like pleckstrin homology (PH)
domains and FYVE domains targets proteins to specific
parts of the membrane. Proper signal transduction by
phosphoinositides requires a tight control of their local
concentrations. The formation of clathrin-coated vesicles
and phagocytic cups is accompanied by the localized
production of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2)
and phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3),
respectively (3,4). One group of enzymes regulating the
formation and degradation of phosphoinositides are inosi-
tol 5-phosphatases [reviewed by Erneux et al. (5)]. These
enzymes remove the phosphate group from the 5-position
of the inositol ring. The mammalian inositol 5-phosphatase
SHIP (SRC Homology 2 Domain-containing Inositol-5-
Phosphatase) is recruited to the membrane of the phago-
cytic cup, and negatively regulates phagocytosis (6). The
inositol 5-phosphatase synaptojanin regulates vesicle re-
cycling in the synapse (7). A role in vesicle trafficking is
also proposed for the inositol 5-phosphatase OCRL (oculo-
cerebrorenal syndrome of Lowe) (8). This protein contains
a catalytic inositol 5-phosphatase domain and a C-terminal
RhoGAP domain and localizes to transGolgi network (TGN)
in fibroblasts (8), consistent with a role of OCRL in lyso-
somal enzyme trafficking from the TGN to lysosomes (9).
More recently, it has been demonstrated that OCRL pro-
tein associates with clathrin, localizes to endosomes and is
proposed to play a role in clathrin-mediated trafficking of
proteins from endosomes to the TGN (10,11). Mutations in
the gene coding for OCRL results in the oculocerebrorenal
syndrome of Lowe, affecting functions of the lens, kidney
and nervous system (12). At a molecular level, elevated
levels of PI(4,5)P2 are observed (13,14) and the amount of
long actin stress fibers in fibroblasts is decreased (15).
As in mammalian cell lines, phosphoinositides are also
involved in endocytosis in the social amoebaDictyostelium
discoideum [reviewed in (16)]. Their natural food source,
bacteria, are ingested via phagocytosis and the commonly
used strain AX3 grows axenically by means of macro-
pinocytosis. Inhibitors of the enzyme phospholipase C (PLC),
which converts PI(4,5)P2 into inositol 1,4,5-trisphosphate
and diacylglycerol, drastically reduce the rate of phago-
cytosis (17). However, inactivation of the gene encoding the
single D. discoideum PI(4,5)P2–PLC does not affect growth
(18). This suggests that the cells can switch to a PLC-
independent pathway. Inactivation of the PI(3,4,5)P3 pro-
ducing phosphatidylinositol 3-kinases (PI3Ks) DdPIK1 and
DdPIK2 decreases the rate of pinocytosis; however,
phagocytosis is only slightly inhibited (19). On the other
hand, both pinocytosis and growth on Klebsiella aerogens
are inhibited by inactivation of the inositol 3-phosphatase
PTEN (Phosphatase and Tensin-Homolog) (20). Five inositol
5-phosphatases, Dd5P1–4 and PLIP (phospholipid-inositol
phosphatase), have been identified in D. discoideum
(21,22). Dd5P1–4 are inositol 5-phosphatases contain-
ing the conserved motifs I and II (WXGDXN(Y/F)R and
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P(A/S)W(C/T)DR(I/V)L) that are characteristic for inositol
5-phosphatases. The catalytic domain of Dd5P1 shows the
highest similarity with SHIP, but lacks the N-terminal SH2
domain. A unique domain composition is present in Dd5P2
containing a 5-phosphatase and a RCC1-like domain. Dd5P3
and Dd5P4 have a domain composition similar to synapto-
janin with a Sac1 domain, and to OCRL with a RhoGAP
domain, respectively (Figure 1A). PLIP is not a classical
inositol 5-phosphatase, as it does not contain the conserved
motifs I and II. In stead, the amino acid sequence shows
highest similarity with the inositol 3-phosphatase PTEN,
although the preferred in vitro substrate is PI(5)P.
Figure 1: Protein domain composition and alignment of Dd5P4 and OCRL, and phylogeny of the OCRL family. A) Domain
composition of Dictyostelium discoideum Dd5P4 and human OCRL. The abbreviation 5-Pase stands for inositol 5-phosphatase catalytic
domain. B) Amino acids conserved between the RhoGAP domains of human RhoGAP, D. discoideum Dd5P4 and human OCRL are shown
in black (100% identity) or gray (100% similarity). Asterisks indicate amino acids that interact with a small G protein as suggested by the
crystal structure of RhoGAP in complex with RhoA. The arrow indicates the catalytic arginine present in the protein RhoGAP but absent in
Dd5P4 and OCRL. C) Phylogeny of the OCRL family. Proteins that harbor both an inositol 5-phosphatase catalytic domain and a RhoGAP
domain were identified from protein databases. The tree was built using CLUSTALW sequence alignment and PHYLIP (for the alignment we
used the entire sequences from the beginning of the 5-phosphatase domain till the last amino acid, see Materials and Methods section).
Numbers in the tree indicate bootstrap values in percent; the asterisk indicates bootstrap values below 50%. Species and GenBank entry
numbers are: Homo sapiens (Human) OCRL, 67477390; Mus musculus (Mouse) OCRL, 46195807; Takifugu rubripes (Fugu) OCRL,
SINFRUP00000157508; H. sapiens (Human) 75 kDa, 55665969; M. musculus (Mouse) 115 k[t1] , 7513696; T. rubripes (Fugu) 75 k,
SINFRUP00000153548; Apis mellifera (honeybee), 66521204; D. discoideum, 60475249; Anopheles gambiae, 57924096; Drosophila
melanogaster, 2749755; Caenorhabditis elegans, 3874363; Trypanosoma brucei, 70831128; Leishmania major, 68125488; Entamoeba
histolytica, 67482035 (1), 67470251 (2), 56468394 (3), 67467066 (4); Gibberella zeae, 42546878; Neurospora crassa, 18376182;
Magnaporthe grisea, 38108761; Aspergillus fumigatus, 66851486; Aspergillus nidulans, 40742343; Cryptococcus neoformans,
50255557; Yarrowia lipolytica, 49646035.
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Inactivation of dd5p1, dd5p2, dd5p3 or PLIP does not affect
growth or development. In contrast, inactivation of dd5p4
reduces axenic growth and inhibits growth on K. aerogens,
suggesting a function for Dd5P4 in endocytosis (21).
In this report, we investigated the role of Dd5P4 during
phagocytosis and showed that Dd5P4 is essential for
this process. Mutational analysis shows that the inositol
5-phosphatase catalytic domain of Dd5P4 is essential for
complementation of the dd5p4-null cells. Transfection
of dd5p4-null cells with a truncated Dd5P4 lacking the
C-terminal RhoGAP domain does not restore endocytic
defects, suggesting that the C-terminal RhoGAP domain is
essential as well (21). We expressed the human homolog
OCRL in D. discoideum dd5p4-null cells and showed that
expression of OCRL largely restores phagocytosis, growth
and developmental defects of dd5p4-null cells.
The requirement for a functional inositol 5-phosphatase
catalytic domain suggests that Dd5P4 regulates endocy-
tosis by conversion of phosphoinositides. Recent data (23)
have shown that PI(3,4,5)P3 is formed in the early phago-
cytic cup upon contact of the particle, whereas PI(3,4)P2 is
formed later, shortly before and during cup closure. Based
on our results in dd5p4-null cells with the PI(3,4)P2/
PI(3,4,5)P3 reporter PH domain of cytosolic regulator of
adenyl cyclase coupled to green fluorescent protein
(PHcrac-GFP), we suggest that Dd5P4mediates the conver-
sion of PI(3,4,5)P3 to PI(3,4)P2 at the phagocytic cup, which
is necessary for completion of the phagocytic process.
Results
Phylogeny of Dd5P4 and other OCRL-related proteins
Both D. discoideum Dd5P4 and human OCRL consist of an
N-terminal 5-phosphatase domain and a C-terminal Rho-
GAP domain. We searched for the presence of the com-
bination of these two domains in other proteins; databases
were searched with BLAST, while domains were analyzed
with SMART (seeMaterials and Methods section). The com-
bination of an inositol 5-phosphatase domain and a Rho-
GAP domain is not observed in prokaryotes and only in a
limited number of eukaryote species (Figure 1). Protein
sequence alignment and the SMART domain scores reveal
a well-defined 5-phosphatase domain in all these proteins,
and a less well-defined RhoGAP domain. The RhoGAP
domain has high SMART scores (<1  1033) in the proteins
present in metazoan and D. discoideum, intermediate SMART
scores for parasites Leishmania major, Trypanosoma bru-
cei and Entamoeba histolytica (about 1  105) and
detectable but insignificant scores for fungi (>1  101).
Interestingly, the 150 amino acid protein segment
between the 5-phosphatase and RhoGAP domain shows
rather good alignment.
Phylogenetic analysis of the OCRL family of proteins
reveals that vertebrates contain two isoforms, OCRL and
the 75-kDa type II 5-phosphatase. Insects, nematodes,
D. discoideum and parasites contain only one gene, sug-
gesting that the two isoforms in vertebrates evolved by
relatively recent gene duplication. Entamoeba histolytica,
a single-celled eukaryote parasite, contains four OCRL-like
sequences that are not very homologous, suggesting that
they are the result of early duplications in the lineage to
Entamoeba. OCRL-like proteins are found in many fungi,
but not in the yeast strains Saccharomyces cerevisiae and
Schizosaccharomyces pombe. Also plants do not contain
OCRL-like proteins with a 5-phosphatase and RhoGAP
domain.
The position of theD. discoideum protein Dd5P4 relative to
the proteins of other species is rather unexpected. It has
been well established using phylogeny of many proteins
thatD. discoideum species evolved after plants, but before
the fungi, and certainly far before Caenorhabditis elegans
and Drosophila melanogaster. Nevertheless, the D. dis-
coideum OCRL-like protein groups closer to vertebrate
OCRL than the proteins from C. elegans, D. melanogaster
and fungi. This close relationship is because of the good
homology between human andD. discoideum protein over
the entire sequence, especially the less-conserved Rho-
GAP domain. Therefore, D. discoideum protein Dd5P4
may represent a good candidate to study the function of
human OCRL.
Inactivation of Dd5P4 inhibits macropinocytosis and
phagocytosis
The commonly used D. discoideum strain AX3 grows both
axenically and on bacterial lawns by means of macro-
pinocytosis and phagocytosis, respectively. Inactivation of
the gene coding for inositol 5-phosphatase Dd5P4 reduces
growth rates in axenic medium and on bacterial lawns to
32  3% and 22  8%, respectively (21, Table 1). The
doubling time of wild-type cells with control plasmid is
15.7  1.2 h, and increased drastically to 48.1  3.6 h in
dd5p4-null cells.When plated in associationwith K. aerogens
as food source, wild-type AX3 cells form visible plaques
after 3 days with a plating efficiency of 48  2%. In this
assay, only 10.3  0.6% of dd5p4-null cells form plaques.
In addition, the plaques of dd5p4-null cells increased in size
at approximately 1/5th the rate of wild-type AX3 cells
(Table 1). To directly measure phagocytosis, we labeled
heat-killed yeast cells with TRITC (Tetramethyl Rhodamine
Iso-Thiocyanate) and measured uptake of these yeast
particles by D. discoideum. Wild-type AX3 ingested about
1.5 yeast particles per hour per cell. Inactivation of Dd5P4
almost completely inhibited phagocytosis to about 4% of
wild-type AX3 cells (Figure 2A; see also Figure 6B and
Table 1).
Proteins are easily expressed in D. discoideum by placing
the gene under the D. discoideum actin 15 promotor,
transfecting the cells and selecting for transfected cells
with G418. The actin 15 promotor ensures expression
in the vegetative state as well as during development.
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Expression of Dd5P4-GFP, a protein in which GFP is
C-terminally fused to Dd5P4, in dd5p4-null cells restored
the defects in phagocytosis of yeast cells and growth on
bacteria as well as growth in axenic medium (Figure 2A,
Table 1). In fact, the rate of yeast phagocytosis (but not
growth on bacteria or in axenic medium) by dd5p4/
Dd5P4-GFP cells exceeded the rate of phagocytosis of
wild-type AX3 cells to 141% of wild type. Overexpression
of Dd5P4-GFP in wild-type cells also increased phagocy-
tosis of yeast cells to 133%ofwild type (Figure 2A, Table 1).
Expression of Dd5P4-GFP allows for the study of the
localization of Dd5P4. In both vegetative and starved cells,
Dd5P4-GFP was localized in the cytosol. We could not
observe any localization to internal structures or the
plasma membrane. Although the cells formed macropino-
cytic cups, no localization to the cups or endosomes was
observed. Also no membrane localization of Dd5P4-GFP
was observed in cells during phagocytosis of yeast
particles (Figure 3).
The catalytic domain and the RhoGAP domain are
essential for Dd5P4 function
Two conserved motifs, WXGDXN(Y/F)R and P(A/S)W(C/T)
DR(I/V)L, are characteristic for inositol 5-phosphatases.
Based on the crystal structure of the 5-phosphatase
Table 1: Doubling time and rate of phagocytosis of used cell lines
Parental strain Plasmid Growth in axenic
medium (% of control)
Phagocytosis (% of control)
Growth on bacteria Yeast uptake
Plating efficiency Plaque growth
AX3 Control plasmid 100 (def) 100 (def) 100 (def) 100 (def)
Dd5P4-GFP 98  10 116  3* 120  22* 133  7*
Dd5P4D319A-GFP 79  9* 98  4 89  12* 90  3*
OCRL 94  9 100  7 105  16 ND
OCRLD422A 102  9 96  6 97  14 ND
Dd5p4 None 32  3* 21  1* 22  8* 3.7  1.7*
Control plasmid 34  5* 22  4* 20  8* ND
Dd5P4-GFP 95  10 84  4* 95  16 141  16*
Dd5P4 107  8 99  2 116  17* ND
Dd5P4D319A-GFP 31  3* 18  2* 26  7* 0  3*
Dd5P4DRhoGAP 37  4* 17  1* 28  8* ND
OCRL 84  9* 65  4* 59  23* 22.6  4.8*
OCRLD422A 31  3* 22  2* 27  6* ND
For growth in axenic medium, we determined the doubling time of each cell line. The results shown are the doubling time of AX3 with
control plasmid (15.7  1.2 h; mean  standard deviation, n ¼ 6) divided by the doubling time of the mutant. The doubling time of AX3
without vector is 12.6 0.6 h. For growth on bacteria, we plated 250 or 1000 cells on solid medium in association with Klebsiella aerogens.
After 3 and 4 days, the number and size of the colonies was determined. Shown are the plating efficiency of the mutant strain divided by
the plating efficiency of AX3 with control plasmid (48  2%; n ¼ 4), and the plaque size of the mutant strain divided by the plaque size of
AX3 with control plasmid on day 3 (2.5  1.1 mm; n ¼ 16). For phagocytosis of yeast cells, we measured the uptake of fluorescent yeast
particles, expressed as a percentage of the rate of yeast uptake of AX3 with control plasmid (1.51  0.08 yeast cells per Dictyostelium
discoideum cell per hour; n ¼ 3). ND, not determined. An asterisk indicates a significant difference to AX3 with control plasmid (p < 0.01).
Figure 2: Axenic growth and phagocytosis of
Dd5P4 mutants. Shown is the average of three
experiments for yeast cell internalization (A) and
a representative of the growth curves in axenic
medium (B) of AX3 (closed circles), AX3/Dd5P4-
GFP (closed diamonds), AX3/Dd5P4D319A-GFP
(closed triangle), dd5p4 (open circles), dd5p4/
Dd5P4 (open diamonds) and dd5p4/Dd5P4D319A-
GFP (open triangles).
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catalytic domain of SPsynaptojanin (Schizosaccharomyces
pombe Synaptojanin), the aspartate present in the first
motif was implicated to act as the catalytic base in the
dephosphorylation reaction (24). This is supported by
the fact that replacement of this aspartate by an alanine
in the human platelet 75-kDa inositol polyphosphate 5-
phosphatase II renders a 5-phosphatase inactive version
of the protein (25). We mutated the corresponding
aspartate in Dd5P4-GFP, Asp319, to an alanine and ex-
pressed the protein (Dd5P4D319A-GFP) in a dd5p4-null back-
ground. Confocal fluoresence microscopy reveals that
Dd5P4D319A-GFP shows the same cytosolic localization as
Dd5P4-GFP, both in a wild-type and in a dd5p4-null back-
ground (see Figure S1), implicating that the mutated protein
was expressed at approximately equal levels as the wild-
type protein. The growth rate in axenic medium (Figure 2B)
or on bacterial lawn (Table 1) was not significantly restored
in dd5p4/Dd5P4D319A-GFP cells compared to dd5p4 cells
(Figure 2B, Table 1). Uptake of yeast particles by dd5p4/
Dd5P4D319A-GFP cells was below detection levels, which
is significantly lower than the uptake by dd5p4 cells
(Figure 2A, Table 1). Overexpression of this catalytic inac-
tive 5-phosphatase in wild-type cells (AX3/Dd5P4D319A-
GFP) lead to a statistically significant reduction of axenic
growth by 21%, growth on bacteria by 11% and phagocy-
tosis of yeast cells by 10% (Table 1). This inhibition could
be due to competition of endogenously expressed wild-
type Dd5P4 with the exogenously expressed catalytic
inactive Dd5P4D319A-GFP.
Dd5P4 contains a 5-phosphatase and a RhoGAP domain.
We expressed a deletion mutant containing the active
catalytic domain (21), but not the RhoGAP domain. These
dd5p4/Dd5P4DRhoGAP cells exhibited similar growth rates
as dd5p4 cells, both in axenic medium and on bacteria,
suggesting that an active catalytic domain is not sufficient
to complement the dd5p4 cells. These studies implicate
the necessity of both the inositol 5-phosphatase cata-
lytic domain and the RhoGAP domain to restore growth
defects.
We also expressed Dd5P4 without GFP tag in dd5p4-null
cells because the C-terminal GFP tag may interfere with
the function of the essential RhoGAP domain. We
observed that Dd5P4 complemented dd5p4 cells slightly
better than Dd5P4-GFP. The 10–20% faster growth in
axenic medium and on bacteria is statistically significant.
The PH domain of CRAC localizes to the phagocytic
and pinocytic cup in dd5p4-null cells
As phagocytosis is almost completely blocked in dd5p4-
null cells, we wondered at which step of particle internal-
ization the process was inhibited. The PI(3,4)P2/PI(3,4,5)P3
reporter protein PHcrac-GFP localizes to the phagocytic
cup (23,26). We studied PHcrac-GFP localization in wild-
type and dd5p4-null cells by confocal microscopy. The use
of yeast particles labeled with TRITC allowed the detection
of both PHcrac-GFP and the yeast cell. Images are
presented in Figure 4 and quantitative data in Figure 5. In
wild-type cells, contact of the cell with a yeast particle
frequently triggered the formation of a PHcrac-GFP patch.
This patch is restricted to the area of contact and increases
in size upon extension of the phagocytic cup [(23,26),
Figure 4A,B). Subsequently, the particle was engulfed and
PHcrac-GFP dissociated from the membrane surrounding
the particle within 1 min after internalization. On average,
we observed approximately one phagocytic attempt per
10 min, which all resulted in a successful uptake of the
yeast particle (Figure 5A). In dd5p4-null cells, interaction of
the yeast particle with membrane components of the cell
triggered the formation of a PHcrac-GFP patch as in wild-
type cells (Figure 4C). The patch was located at the area in
contact with the yeast cell and the intensity of the PHcrac-
GFP patch was not drastically changed compared to wild-
type cells. In addition, the frequency of interaction of
dd5p4-null cells with yeast particles was approximately
identical to that of wild-type cells (Figure 5A). However,
these attempts were rarely successful, and we did not
observe dd5p4-null cells in which the membrane extended
beyond half of the yeast particle. In general, themembrane
extensions of the phagocytic cup were withdrawn, the
PHcrac-GFP patch disappeared and the yeast particle was
subsequently released. In the rare case that we did
observe an internalized yeast particle, some of these yeast
particles were still labeled with PHcrac-GFP (Figure 4D).
As a consequence, after 30 min of incubation with yeast
particles, dd5p4-null cells contain only 0.06  0.23 yeast
particles/cell, compared to 0.96  0.17 yeast particles/cell
in wild-type AX3 cells. We conclude that dd5p4-null cells
effectively recognize, bind and respond to yeast particles
with enhanced PHcrac-GFP localization in the phagocytic
cup, but that the phagocytic process is not completed.
We also used the PI(3,4)P2 reporter TAPP1-PH-GFP in
order to detect PI(3,4)P2 specifically. As observed by
Figure 3: Localization of Dd5P4.
Dd5p4-null cells were transfected with
Dd5P4-GFP and analyzed by confocal
microscopy. A vegetative cell is de-
picted in the left panel and cells ingest-
ing yeast particles in the middle and
right panel. The solid arrows indicate
the yeast particles. The bar is 3 mm.
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Dormann et al. (23), in wild-type cells TAPP1-PH-GFP was
not yet present at the membrane in the first steps of
phagocytosis, but was detected just before cup closure.
Unfortunately, we have been unable to transform the
dd5p4-null cell line with the TAPP1-PH expression vector
to investigate the formation of PI(3,4)P2 during pinocytosis
and phagocytosis. In three independent experiments, we
observed small clones of cells resistant to the selection
Figure 5: Formation and closure of phagocytic and pinocytic cups. AX3 cells and dd5p4-null cells transfected with PHcrac-GFP were
incubated for about 30 min with TRITC-labeled yeast particles, and analyzed by confocal microscopy for 2 min as in Figure 4. For
phagocytosis (A), we determined the number of events per minute of cells that made contact with a yeast particle and exhibited enhanced
localization of PHcrac-GFP at the site of interaction, which is defined as attempts. In successful attempts, the yeast particle is engulfed. For
pinocytosis (B), we determined the number of pinocytic cups stained with PHcrac-GFP per cell per minute, and the number of closed
pinocytic cups visible as vesicles.
Figure 4: Localization of PHcrac-
GFP in AX3 and dd5p4 cells during
endocytosis. AX3 cells transfected
with PHcrac-GFP (A,B) and dd5p4-
null cells transfected with PHcrac-
GFP (C,D) were incubated with
TRITC-labeled yeast particles and
analyzed by confocal microscopy.
The time indicated in the corner of
the picture is the time in seconds.
Arrows point to the formation of
a pinocytic cup. In panel C, the initial
phagocytic cup is labeled with
PHcrac-GFP, which is a common
event for wild-type and dd5p4-null
cells, but the yeast cell is not en-
gulfed by the dd5p4-null cells. In
panel D, the membrane surrounding
an internalized yeast cell is labeled
with PHcrac-GFP in the first frames
before the yeast cell moves out of
the confocal plane. Internalized yeast
cells as shown in panel D are com-
mon for wild-type cells, but rarely
observed in dd5p4-null cells (see also
Figure 5). The bar is 3 mm.
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marker, but cells died when the clones contained between
10 and 20 cells, suggesting that expression of TAPP1-PH-
GFP in dd5p4-null cell is lethal.
PHcrac-GFP patches are not only induced upon binding of
yeast particles but are also formed at the membrane at
apparently random places. In most cases, a pinocytic cup
is formed at these positions and liquid is internalized.
Localization of PHcrac-GFP to the endosome is visible up
to 1 min after internalization. In the dd5p4-null cells, we
observed similar structures as in wild-type cells with
PHcrac-GFP patches, pinocytic cups and closed macro-
pinosomes (Figure 4B,D). However, the frequency at
which these structures appear are much lower in dd5p4-
null cells (0.33 pinocytic cup/cell/min) than in wild-type
cells (1.33 pinocytic cup/cell/min). For wild-type cells, we
observed that approximately half of the pinocytic cups
closed, yielding a macropinosome visible in the confocal
plane, which was also observed in dd5p4-null cells (Fig-
ure 5B). We conclude that pinocytic cups labeled with
PHcrac-GFP were formed at a reduced rates in dd5p4-null
cells, but that subsequent cup closure and PHcrac-GFP
localization to endosomes were not different from wild-
type cells.
Expression of human OCRL largely rescues
dd5p4-null cells
Sequence analysis of the inositol 5-phosphatase Dd5P4
has revealed the presence of a C-terminal RhoGAP domain
(21). Human OCRL contains a C-terminal RhoGAP domain
similar to Dd5P4 (Figure 1). Furthermore, both the inositol
5-phosphatase catalytic domain and RhoGAP domain of
OCRL have a relatively high similarity with the correspond-
ing domains of Dd5P4 (see above). Because of these
similarities, we expressed human OCRL in dd5p4-null cells
and analyzed the recovery in growth and phagocytosis.
Expression of OCRL does restore axenic growth almost to
the rate of wild-type cells, although the final cell density
does not reach wild-type levels (Figure 6A, Table 1). When
plated in association with K. aerogens as food source for
3 days, wild-type AX3 cells have formed plaques with
a size of 2.5 1.1 mm at a plating efficiency of 48 2%. In
this assay, the plaques of dd5p4-null cells are only 0.5 
0.2 mm in size at a significantly lower plating efficiency of
10.3  0.6%. The dd5p4/OCRL cells exhibit a plaque size
of 1.5  0.5 mm and plating efficiency of 30  2% that are
intermediate between dd5p4 cells and wild-type cells.
We also tested the uptake of yeast cells. Whereas the rate
of yeast uptake for dd5p4-null cells is about 4% of wild-
type AX3 cells, the rate of phagocytosis of dd5p4-null
cells expressing OCRL is increased about fivefold to 23%
of wild-type cells (Figure 6B, Table 1). Expression of
OCRLD422A with a mutation of the catalytic aspartate does
not restore growth on bacteria or in axenic medium, in-
dicating that OCRL, as Dd5P4, must be catalytically active
to support growth.
Upon starvation, D. discoideum cells form multicellular
aggregates. A single tip is formed at the top of the
aggregate, and organizes the development into a multicel-
lular slug and eventually a fruiting body with spores.
Starvation of dd5p4-null cells results in the formation of
multiple-tipped aggregates and consequently small fruiting
bodies (21). Expression of OCRL in dd5p4-null cells
restores this defect; cells form normal aggregates, slugs
and fruiting bodies (data not shown). The results reveal
that human OCRL can replace Dd5P4: phagocytosis of
yeast particles is partly restored, plating efficiency and
growth on bacterial lawns is largely restored, whereas
growth on axenic medium andmulticellular development is
nearly completely restored.
Discussion
In mammalian cell lines, endocytosis and vesicle trafficking
are regulated by phosphoinositides. In D. discoideum, the
commonly used PI(3,4)P2/PI(3,4,5)P3 reporter PHcrac-GFP
Figure 6: OCRL complements growth
defects of dd5p4-null cells. Shown is
a representative of the growth curves in
axenic medium (A) and the average of
three phagocytosis assays (B) of AX3
(closed circles), dd5p4 (open circles),
dd5p4/OCRL (closed triangles).
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is located at the pinocytic and phagocytic cup until
about 1 min after internalization, suggesting a function
for phosphoinositides in endocytosis of D. discoideum
cells as well (23,26). Inactivation of two D. discoideum
PI3Ks, DdPIK1 and DdPIK2, inhibits pinocytosis and inac-
tivation of the 3-phosphatase PTEN inhibits growth on liquid
medium and bacteria, supporting a function for phosphoi-
nositides in pinocytosis and phagocytosis (20,27,28).
Function of inositol 5-phosphatase activity during
endocytosis
Inactivation of the inositol 5-phosphatase dd5p4 results in
growth defects, indicating that Dd5P4 participates in
endocytosis by regulating phosphoinositide levels (21).
This is supported by data presented in this report showing
that, in contrast to wild-type Dd5P4, the inositol 5-phos-
phatase inactive protein Dd5P4D319A-GFP did not comple-
ment the growth defects of dd5p4-null cells, and even
inhibited growth upon expression in wild-type cells.
PI(4,5)P2 and PI(3,4,5)P3 are degraded in vitro by the
catalytic domain of Dd5P4 (21). As PI(4,5)P2 is the sub-
strate for PI(3,4,5)P3 production, reduced degradation of
PI(4,5)P2 or PI(3,4,5)P3 in vivo could both lead to an
increase of PI(3,4,5)P3 levels.
Upon binding of a yeast cell, wild-type D. discoideum cells
form a phagocytic cup. The sides of the cup extend along
the yeast cell and eventually enclose the particle by fusion
of the extending membranes. Yeast cells were still de-
tected by the dd5p4-null cells at a normal frequency, and
small phagocytic cups with membrane extension around
the particles were formed as in wild-type cells. However,
we rarely observed in dd5p4-null cells the further formation
of cups that extended beyond half of the yeast cell or the
subsequent fusion of extending membranes. As for wild-
type cells, PHcrac-GFP localized to the membrane of
dd5p4-null cells that was in contact with the yeast cell
and the intensity of the PHcrac-GFP patch was not visibly
altered if compared to wild type. This suggests that the
total amount of PI(3,4)P2/PI(3,4,5)P3 was not drastically
changed in dd5p4-null cells. As lack of inositol 5-phospha-
tase activity hampers phagocytosis, we suggest that the
conversion of PI(3,4,5)P3 to PI(3,4)P2 is necessary for
extension and closure of the phagocytic cup.
Dormann et al. (23) reported on the identity of the
phosphoinositides that are formed during pinocytosis and
phagocytosis using PH-GFP fusions that are specific for
PI(3,4,5)P3 (GRP1-PH-GFP) or for PI(3,4)P2 (TAPP1-PH-
GFP); PHcrac-GFP detects both PI(3,4,5)P3 and PI(3,4)P2.
It was shown that during phagocytosis, PI(3,4,5)P3 is
formed upon attachment of the particle to the cell, while
PI(3,4)P2 becomes detectable significantly later in the
process, just before and during cup closure. Transforma-
tion of dd5p4-null cells with the TAPP1-PH expression
vector yielded cells that died when the clones contained
between 10 and 20 cells. Wild-type cells could be trans-
formed with the TAPP1-PH vector, and we confirmed the
observations of Dormann et al. (23). Although many
technical explanations are possible for these negative
results, we suspect that expression of the PH domain of
TAPP1 in dd5p4-null cell is lethal; dd5p4-null cells grow
very slowly because of the reduced conversion of
PI(3,4,5)P3 to PI(3,4)P2 at the closure of the endocyctic
cup, and binding of the residual PI(3,4)P2 by the PH domain
of TAPP1 may block endocytosis completely. The study by
Dormann et al. (23) and our previous and present experi-
ments strongly suggest that the Dictyostelium OCRL-like
protein Dd5P4 is responsible for the conversion of
PI(3,4,5)P3 to PI(3,4)P2 at the closure of the phagocyctic
cup. In this way, Dd5P4 and PI(3,4)P2 may act as a condi-
tional timer for completion of phagocytosis. In the absence
of functional Dd5P4, either because of inactivation of the
inositol 5-phosphatase activity or deletion of the RhoGAP
domain, phagocytosis stalls halfway and the particle is
released.
Implications of the restored endocytic defects by
OCRL
In this report, we show that human OCRL can partly
complement dd5p4-null cells for the lack of Dd5P4.
Phagocytosis of yeast cells, that is strongly inhibited in
dd5p4-null cells, is restored partly by OCRL from 4 to 22%,
whereas the milder growth defects of dd5p4-null cells are
restored from 21 to 62% (growth on bacteria) and from 32
to 84% (growth in axenic medium). Mutation of the
catalytic aspartate of Dd5P4 renders the protein inactive
in complementing dd5p4-null cells. The corresponding
catalytic mutation in OCRL does also not complement
dd5p4-null cells, suggesting that OCRL exhibits 5-phos-
phatase activity in D. discoideum. Several mutations in the
OCRL gene of patients with Lowe syndrome have been
identified leading to reduced 5-phosphatase activity (13).
Dd5P4 contains a C-terminal RhoGAP domain in addition
to the inositol 5-phosphatase catalytic domain. This domain
is not present in either one of the remaining inositol
5-phosphatases in dd5p4-null cells, the SHIP-like Dd5P1,
the unique Dd5P2 and the synaptojanin-like Dd5P3. Trans-
fection of dd5p4-null cells with an extrachromosomal
plasmid only containing the catalytic domain of Dd5P4
does not restore any of the observed defects in dd5p4-null
cells, including poor growth on bacteria. These observa-
tions strongly implicate an essential function for the
RhoGAP domain, next to the 5-phosphatase domain,
and also suggest the presence of a small G protein in
D. discoideum cells that can bind both the RhoGAP domain
of Dd5P4 and human OCRL.
The phylogenetic cluster analysis of OCRL-like proteins
with inositol 5-phosphatase and RhoGAP domains reveals
an unexpected close relationship between Dictyostelium
OCRL-like Dd5P4 and vertebrate OCRL. Many OCRL-like
proteins from lower eukaryotes have a poorly conserved
RhoGAP domain. In contrast to other lower eukaryotes,
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the RhoGAP domain of Dd5P4 has relatively high similarity
with the RhoGAP domain of OCRL. In fact, the RhoGAP
domain of Dd5P4 is more closely related to the RhoGAP
domain of the human inositol 5-phosphatases OCRL than
to other D. discoideum RhoGAP domains present in the
data bank. Saccharomyces cerevisiae do not possess
OCRL-like proteins with a RhoGAP domain, but three
synaptojanin-like inositol 5-phosphatases and one inositol
5-phosphatase not containing another identified domain.
Human OCRL-like 5-phosphatase II restores the pheno-
typic defects of null mutants of these inositol 5-phospha-
tases (29), suggesting that the 5-phosphatase activity of
OCRL is sufficient for complementation in yeast. How-
ever, the necessity of a RhoGAP domain for Dd5P4
function in D. discoideum makes Dd5P4 a good candidate
to serve as a model for human OCRL.
Recently, it has been reported that the RhoGAP domain of
humanOCRL binds to the small G protein Rac1 (30,31). For
D. discoideum, human Rac1 is closely related to the
Dictyostelium Rac1A-C family (unpublished data). Interest-
ingly, it has been demonstrated that the Rac1 family of
small G proteins is involved in endocytosis in D. discoi-
deum (32). Human OCRL is localized to the TGN, but does
not contain a membrane-targeting domain (8,12). As small
G proteins are prenylated and thereby targeted to the
membrane, binding of OCRL to Rac1 could mediate the
localization of OCRL. Extrapolation of these data to
D. discoideum would implicate a role for the RhoGAP
domain in membrane localization and explain the require-
ment for a RhoGAP domain. However, as we could not
observe membrane localization of Dd5P4 under the con-
ditions tested, either the interaction with the small G
protein is too transient, or the amounts of interacting
proteins is too low or the RhoGAP domain does not func-
tion as a membrane-targeting domain in D. discoideum.
Expression of human OCRL in dd5p4-null cells restores the
endocytic defects, but not to wild-type levels. This could
be as a result of poor expression of human OCRL in
D. discoideum, to less efficient binding of OCRL to the
D. discoideum small G protein and/or to lower GTPase
activating protein activity of OCRL compared to Dd5P4.
The crystal structure of the human RhoGAP, which is
homologous to the RhoGAP domain of Dd5P4 and OCRL,
has been solved in complex with the small GTP-binding
protein RhoA (33). This revealed a catalytic role for an
arginine, Arg85p50RhoGAP, located at the loop between helix
A and A1. This loop, together with helix B and F, formmost
of the interactions between RhoGAP and RhoA. Many of
the amino acids that interact with the small G protein,
including the catalytic arginine, are not conserved in both
Dd5P4 and OCRL (Figure 1). Furthermore, a number of
these amino acids in Dd5P4 are also not similar to the
corresponding amino acids in OCRL. This supports the idea
that less efficient binding of the RhoGAP domain of OCRL
to the D. discoideum small G protein may cause the partial
rescue of phagocytosis.
Materials and Methods
Phylogeny of OCRL-related proteins
Genomic and protein databases were searched with BLAST (http://
www.ncbi.nlm.nih.gov) for the presence of proteins containing both
5-phosphatase and RhoGAP domains. Initial searches were carried out
with the complete open reading frame of human OCRL and D. discoideum
Dd5P4, yielding sequences from metazoan, some parasites and some
fungi. Domain architecture was analyzed with SMART (smart.embl-heidel-
berg.de), indicating very high scores for the 5-phosphatase domains (about
1  10140 for metazoan, 1  10123 for D. discoideum and 1  1030
for parasites and fungi), but lower scores for the RhoGAP domain (about
1 1040 for metazoan, 1 1033 forD. discoideum, 1 105 for parasites
and insignificant 1  10þ1 scores for fungi). Sequence alignment was
performed by CLUSTALW analysis, revealing very good alignment of the
5-phosphatase domain and reasonable alignment of the RhoGAP domain,
but also unexpected good alignment of the 180 amino acids between the
5-phosphatase and RhoGAP domain. Therefore, databases were searched
again with a C-terminal segment of the OCRL or Dd5P4 protein containing
about 50 amino acids of the 5-phosphatase domain, the RhoGAP domain
and the connecting domain, yielding several additional sequences in
Entamoeba and fungi. These new sequences all had a RhoGAP domain
with low scores in SMART. Finally, databases were searched with only the
connecting domain. All proteins with significant BLAST scores contained both
the 5-phosphatase and RhoGAP domain and were already found in the
previous searches.
Phylogenetic analysis was performedwith PHYLIP, using the alignment of the
complete proteins, except the very variable section before the 5-phospha-
tase domain (thus the complete 5-phosphatase domain, RhoGAP domain
and domain between 5-phosphatase and RhoGAP).
Strains and growth conditions
The D. discoideum strains AX3 (wild type), dd5p4-null and derivatives were
grown in HG5 medium and supplemented with 10 mg/mL G418 when
necessary. When grown in shaking culture, the cell density was kept
between 5  105 and 6  106 cells/mL. To determine growth rate, doubling
times were determined in the exponential phase of the growth curve.
Growth and development on bacterial lawns was studied using K. aerogens
grown on 3 LP plates (8.3 mM lactose, 2 mM KH2PO4, 2 mM Na2HPO4,
15 g/L agar). Unless stated otherwise, D. discoideum cells were grown
and assayed at 228C.
Expression of proteins in D. discoideum
To express proteins in D. discoideum, the desired genes were cloned
behind the actin 15 promotor of the extrachromosomal plasmid MB74 or
DM6. These plasmids contain a neomycin cassette, which allows selection
with G418 for cells containing the plasmid. MB74 is a derivative of
MB12neo, in which the terminator in the neomycin cassette has been
replaced by one actin 8 terminator. DM6 is a derivative of MB74 also
containing the gene coding for enhanced GFP. Previously (21), we
described the cloning of full-length Dd5P4 and Dd5P4DRhoGAP (with the
name cat5P4). GFP fusion proteins of Dd5P4 were constructed by poly-
merase chain reaction (PCR) using a reverse primer lacking the stop codon
and in frame fusion with the ‘‘GFP open reading frame’’ in DM6. To obtain
a catalytic inactive mutant, the aspartate at position 319 was mutated into
an alanine by site-directed mutagenesis, simultaneously introducing a SacI
restriction site by silent mutagenesis of Gly318 and Leu320.
Using PCR, the human OCRLwas amplified from pTarget-OCRL and cloned
into MB74, yielding plasmid pOCRL. Based on heterologous expression
studies (34), we optimized the first 13 codons, using the forward primer
OCRL-s1 (AATTAGGATCC ATG GAG CCA CCA CTC CCA GTC GGA GCC
CAA CCA CTT GCC), to obtain proper expression of human OCRL in
D. discoideum. To obtain a catalytic inactive mutant of OCRL, the aspartate
at position 422 was mutated into an alanine by site-directed mutagenesis
with plasmid pOCRL as target, simultaneously introducing a SacI restriction
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site by silent mutagenesis of Leu423. All gene fragments obtained by PCR
were verified by sequencing.
Phagocytosis assay
Heat-killed yeast cells were fluorescently labeled with TRITC (1 mg/1010
yeast particles) and resuspended in phosphate buffer (PB) (10 mM
Na2HPO4/KH2PO4, pH 6.5; 10
9 yeast particles/mL PB) (35). Dictyostelium
discoideum cells were grown in shaking culture, collected and washed
once with PB. Cells were resuspended (2  107 cells/mL PB) and
transferred to glass tubes. Samples (112 mL) were taken after indicated
times of incubation at 150  g with labeled yeast particles (final concen-
tration of 1.1  108 yeast particles/mL). Phagocytosis was stopped by
addition of ice-cold PB (1 mL) and samples were kept on ice. After addi-
tion of 100 mL trypan blue (2 mg/mL in 20 mM citrate, 150 mM NaCl,
pH 4.5) and incubation for 5 min at 200  g, cells were spun down (3 min
at 500  g), resuspended in 1 mL PB and fluorescence was measured
(excitation: 544 nm, emission: 574 nm).
Confocal images
To obtain confocal images of cells ingesting yeast, D. discoideum cells
were washed with PB and TRITC-labeled yeast particles were added. To
obtain confocal images of cells expressing PHcrac-GFP or TAPP1-PH-GFP,
cells were transfected with plasmid WF38 (kind gift of P. N. Devreotes) or
plasmid TAPP1-PH-GFP (kind gift of C. Weijer), respectively.
Images were obtained using a Zeiss LSM510 confocal fluorescence
microscope (Carl Zeiss Jena, Germany) with a Plan-Apochromat  63
magnification 1.40 aperture oil immersion objective. Using an argon laser,
fluorescence of PHcrac-GFP and TRITC-yeast were determined at wave-
lengths 488 nm and 543 nm in combination with a 500–530 nm and
565–615 nm filter, respectively.
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